Annual Report 2011-2012 of Sun Pharmaceutical Industries Limited

It is a broadly described annual report of Sun Pharmaceutical Industries Limited in the year of 2011-2012. During the financial year, The Company’s Total Income Rs. 43584 million. Net Profit after Tax for the year Rs. 16975 million. The Company’s Revenues increased from Rs. 23,801 million in FY 11 to Rs. 29,154 million in FY 12. This includes an element of one time sales of Rs. 1.8 billion in the fourth quarter. Equity shares final Rs. 4401. Book value per equity share of Rs.1/- each Rs. 76/-.

An interim equity dividend of Rs. 4.25 per equity share of face value Rs. 1/- each (previous year Rs. 3.50 per equity share) for the year ended 31^st March 2012 as recommended by the Board of Directors of the Company at their Meeting held on 10^th August 2012 was paid on 22^nd August 2012 to the Equity Shareholders of the Company whose names stood on the Register of Members on 16^th August 2012.

More Annual Report of Sun Pharmaceutical Industries Limited: